Brief Report
Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT
Article first published online: 3 JAN 2008
DOI: 10.1002/mds.21908
Copyright © 2007 Movement Disorder Society
Additional Information
How to Cite
Unger, M. M., Möller, J. C., Stiasny-Kolster, K., Mankel, K., Berg, D., Walter, U., Hoeffken, H., Mayer, G. and Oertel, W. H. (2008), Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT. Mov. Disord., 23: 596–599. doi: 10.1002/mds.21908
Publication History
- Issue published online: 26 MAR 2008
- Article first published online: 3 JAN 2008
- Manuscript Accepted: 11 NOV 2007
- Manuscript Revised: 8 NOV 2007
- Manuscript Received: 20 AUG 2007
Funded by
- BMBF. Grant Number: 01GI0401
- Willy und Monika Pitzer Stiftung
- Abstract
- Article
- References
- Cited By
Keywords:
- Parkinson's disease;
- rapid-eye-movement sleep behavior disorder;
- transcranial sonography;
- substantia nigra hyperechogenicity
Abstract
Idiopathic rapid-eye-movement (REM) sleep behavior disorder (iRBD) has been suggested to be a risk factor for subsequent development of neurodegenerative disorders, especially Parkinson's disease (PD) and other α-synucleinopathies. At present, it is not possible to predict whether or not an iRBD patient will eventually develop PD. Here, we report 5 iRBD patients who underwent a test battery comprising a neurological examination (including UPDRS rating), mini mental state examination testing, transcranial sonography, olfactory function testing, and presynaptic dopamine transporter imaging with FP-CIT-SPECT. Our preliminary data show the diverse pattern of individual combinations of pathological findings when a multimodal assessment approach is applied in this patient group. Large-size longitudinal studies in iRBD patients are required to evaluate the usefulness of diagnostic tests to identify the subgroup of iRBD patients that is prone to develop PD. © 2007 Movement Disorder Society

1531-8257/asset/MDS_left.gif?v=1&s=a99f3b698e6ae32e96dbc75c912d289e5c35649d)
1531-8257/asset/MDS_right.gif?v=1&s=4d3c8316b533aa4e41b7101a2d6fa6f082cf2505)
